755 Pill - orange & white capsule/oblong, 21mm
Pill with imprint 755 is Orange & White, Capsule/Oblong and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 755
Temozolomide
- Imprint
- 755
- Strength
- 180 mg
- Color
- Orange & White
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0755
- Inactive Ingredients
-
alcohol,
ammonia,
lactose anhydrous,
butyl alcohol,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
gelatin,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
shellac,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type B potato,
stearic acid,
tartaric acid,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "755"
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
